Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the detailed record of transactions filed by Ozeroff Christopher David, Conseiller Juridique. Insider active across 1 company, notably ARCA biopharma, Inc.. Cumulatively, 1 reports have been published. Split: 1 buy · 0 sell. Total volume traded: €100k. Activity tracked since 22 November 2021. The latest transaction was disclosed on 22 November 2021 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration
Christopher David Ozeroff is Senior VP and General Counsel at ARCA biopharma, Inc. He oversees the company's legal matters and ensures regulatory compliance. His role is crucial for protecting the legal interests of the organization.